Investors have punished Samsung for the slow progress in advancing its HBM technology, with its share price falling more than 10% in the final quarter of 2024, bringing its losses for the year to ...
Intel Corp. saw further declines in revenue during the latest quarter but beat its guidance on a closely watched margin number, signaling some financial recovery in the business as Chips Act money ...
Due to its significant market share and high gross margins in a structurally growing industry, ResMed has posted an average return on invested capital, or ROIC, of 20% over the last decade. We ...
The stock rose 2% on Thursday and was up another 1% in after-hours action following Visa's (V) own upbeat earnings report, in which the company showed payments volume accelerating. Visa posted 9% ...
BOJ Gov. Kazuo Ueda has said that the economy is on track to reach its goal of stable inflation backed by wage growth. Policymakers expect the nation's chronic labor shortages, amid a declining and ...
Karoon’s balance sheet remains sound following the Who Dat acquisition. From a net cash position of USD 152 million or just over AUD 0.40 per share as of the end of September 2023, the balance sheet ...
Apple Inc. pulled off a major feat for Wall Street, managing to report better-than-expected revenue and earnings in its fiscal first quarter, even amid an unexpected revenue decline in Greater China.
Samsung's flagship chip-making division generated operating profit of about 2.9 trillion won, down from around 3.9 trillion won the prior quarter. The result was way below smaller chip-making rival SK ...
Deckers Brands on Thursday raised its full-year outlook and reported third-quarter results that topped estimates, helped by demand for Ugg boots and Hoka running shoes. But investors, apparently, had ...
All in all, we are cognizant of Gen's strengths as a strong player in the consumer-focused cyber safety space and the challenging landscape the firm occupies. While we view the firm's strategies in ...
Shares of Vertex Pharmaceuticals rose after Journavx, the company's oral non-opioid pain medication, received Food and Drug Administration approval. The Boston company's stock rose 4.3%, to $457.25, ...
Initial jobless claims fell by 16,000 to 207,000 in the week that ended Jan. 25, the Labor Department said Thursday. It's the lowest level in in three weeks. Gold futures set a fresh record on ...